[Change in the excretion of adrenal steroids as dependent on the chlodithane (2,4'-DDD) concentration in the blood of oncological patients].
D015065:17-Hydroxycorticosteroids / Q000652:urine; D015068:17-Ketosteroids / Q000652:urine; D000230:Adenocarcinoma / Q000188:drug therapy / Q000378:metabolism; D000305:Adrenal Cortex Hormones / Q000652:urine*; D000311:Adrenal Glands / Q000187:drug effects; D001943:Breast Neoplasms / Q000188:drug therapy / Q000378:metabolism; D002940:Circadian Rhythm; D005260:Female; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy / Q000378:metabolism; D008297:Male; D008939:Mitotane / Q000097:blood* / Q000627:therapeutic use; D009369:Neoplasms / Q000097:blood / Q000378:metabolism* / Q000652:urine; D011471:Prostatic Neoplasms / Q000188:drug therapy / Q000378:metabolism
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D000305:Adrenal Cortex Hormones; D008939:Mitotane
Izmenenie ékskretsii nadpochechnikovykh steroidov v zavisimosti ot kontsentratsii khloditana (2,4'-DDD) v krovi onkologicheskikh bol'nykh